CN107823150A - 一种可快速分散的片剂及其制备方法 - Google Patents
一种可快速分散的片剂及其制备方法 Download PDFInfo
- Publication number
- CN107823150A CN107823150A CN201711012205.1A CN201711012205A CN107823150A CN 107823150 A CN107823150 A CN 107823150A CN 201711012205 A CN201711012205 A CN 201711012205A CN 107823150 A CN107823150 A CN 107823150A
- Authority
- CN
- China
- Prior art keywords
- tablet
- rapid dispersion
- microcapsule powder
- powder
- oil microcapsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006185 dispersion Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 239000000314 lubricant Substances 0.000 claims abstract description 21
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims description 70
- 239000003094 microcapsule Substances 0.000 claims description 47
- 239000002245 particle Substances 0.000 claims description 43
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 29
- 235000021355 Stearic acid Nutrition 0.000 claims description 21
- -1 epiphysin Chemical compound 0.000 claims description 21
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 21
- 239000008117 stearic acid Substances 0.000 claims description 21
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 19
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 15
- 108010011485 Aspartame Proteins 0.000 claims description 14
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000605 aspartame Substances 0.000 claims description 14
- 235000010357 aspartame Nutrition 0.000 claims description 14
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 14
- 229960003438 aspartame Drugs 0.000 claims description 14
- 239000011230 binding agent Substances 0.000 claims description 14
- 238000007873 sieving Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 12
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 12
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 12
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 12
- 229920001983 poloxamer Polymers 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- 239000008107 starch Substances 0.000 claims description 12
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 11
- 238000005507 spraying Methods 0.000 claims description 11
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 10
- 229930195725 Mannitol Natural products 0.000 claims description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- 239000000853 adhesive Substances 0.000 claims description 10
- 230000001070 adhesive effect Effects 0.000 claims description 10
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 10
- 238000005243 fluidization Methods 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 239000000594 mannitol Substances 0.000 claims description 10
- 235000010355 mannitol Nutrition 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 102000008186 Collagen Human genes 0.000 claims description 9
- 108010035532 Collagen Proteins 0.000 claims description 9
- 229920001436 collagen Polymers 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 9
- 239000007921 spray Substances 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 8
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 235000012907 honey Nutrition 0.000 claims description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 8
- 239000011812 mixed powder Substances 0.000 claims description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 8
- 244000131522 Citrus pyriformis Species 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 235000019202 steviosides Nutrition 0.000 claims description 7
- 239000004408 titanium dioxide Substances 0.000 claims description 7
- 235000010215 titanium dioxide Nutrition 0.000 claims description 7
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 240000001548 Camellia japonica Species 0.000 claims description 6
- 235000005979 Citrus limon Nutrition 0.000 claims description 6
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 6
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 6
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 6
- 239000004383 Steviol glycoside Substances 0.000 claims description 6
- 235000018597 common camellia Nutrition 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 235000015203 fruit juice Nutrition 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 6
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 6
- 235000012680 lutein Nutrition 0.000 claims description 6
- 239000001656 lutein Substances 0.000 claims description 6
- 229960005375 lutein Drugs 0.000 claims description 6
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 6
- 235000012661 lycopene Nutrition 0.000 claims description 6
- 239000001751 lycopene Substances 0.000 claims description 6
- 229960004999 lycopene Drugs 0.000 claims description 6
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 229920001542 oligosaccharide Polymers 0.000 claims description 6
- 150000002482 oligosaccharides Chemical class 0.000 claims description 6
- 239000000049 pigment Substances 0.000 claims description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 6
- 235000013824 polyphenols Nutrition 0.000 claims description 6
- 229920000136 polysorbate Polymers 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 235000019411 steviol glycoside Nutrition 0.000 claims description 6
- 229930182488 steviol glycoside Natural products 0.000 claims description 6
- 150000008144 steviol glycosides Chemical class 0.000 claims description 6
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 6
- 235000020985 whole grains Nutrition 0.000 claims description 6
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 6
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 5
- 244000008991 Curcuma longa Species 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 235000003373 curcuma longa Nutrition 0.000 claims description 5
- 235000012754 curcumin Nutrition 0.000 claims description 5
- 239000004148 curcumin Substances 0.000 claims description 5
- 229940109262 curcumin Drugs 0.000 claims description 5
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 5
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims description 5
- 239000011343 solid material Substances 0.000 claims description 5
- 235000013976 turmeric Nutrition 0.000 claims description 5
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 4
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000001856 Ethyl cellulose Substances 0.000 claims description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 4
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 4
- 244000040738 Sesamum orientale Species 0.000 claims description 4
- 239000004376 Sucralose Substances 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 4
- 229960004998 acesulfame potassium Drugs 0.000 claims description 4
- 239000000619 acesulfame-K Substances 0.000 claims description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 4
- 235000013793 astaxanthin Nutrition 0.000 claims description 4
- 239000001168 astaxanthin Substances 0.000 claims description 4
- 229940022405 astaxanthin Drugs 0.000 claims description 4
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 4
- 229930002875 chlorophyll Natural products 0.000 claims description 4
- 235000019804 chlorophyll Nutrition 0.000 claims description 4
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 4
- 235000015165 citric acid Nutrition 0.000 claims description 4
- 238000004040 coloring Methods 0.000 claims description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 4
- 238000007908 dry granulation Methods 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 4
- 229920001249 ethyl cellulose Polymers 0.000 claims description 4
- 235000021323 fish oil Nutrition 0.000 claims description 4
- 235000004426 flaxseed Nutrition 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 239000001530 fumaric acid Substances 0.000 claims description 4
- 150000002270 gangliosides Chemical class 0.000 claims description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000944 linseed oil Substances 0.000 claims description 4
- 235000021388 linseed oil Nutrition 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 4
- 235000011090 malic acid Nutrition 0.000 claims description 4
- 239000001630 malic acid Substances 0.000 claims description 4
- 229920000609 methyl cellulose Polymers 0.000 claims description 4
- 235000010981 methylcellulose Nutrition 0.000 claims description 4
- 239000001923 methylcellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 claims description 4
- 239000003605 opacifier Substances 0.000 claims description 4
- 238000005453 pelletization Methods 0.000 claims description 4
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims description 4
- 210000002826 placenta Anatomy 0.000 claims description 4
- 239000004014 plasticizer Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 235000019408 sucralose Nutrition 0.000 claims description 4
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- 238000005550 wet granulation Methods 0.000 claims description 4
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 3
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical group CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- 244000221226 Armillaria mellea Species 0.000 claims description 3
- 235000011569 Armillaria mellea Nutrition 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 244000000626 Daucus carota Species 0.000 claims description 3
- 235000002767 Daucus carota Nutrition 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 235000013734 beta-carotene Nutrition 0.000 claims description 3
- 239000011648 beta-carotene Substances 0.000 claims description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 3
- 229960002747 betacarotene Drugs 0.000 claims description 3
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 3
- 239000001354 calcium citrate Substances 0.000 claims description 3
- 235000013736 caramel Nutrition 0.000 claims description 3
- 235000013339 cereals Nutrition 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 235000019197 fats Nutrition 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 229930182470 glycoside Natural products 0.000 claims description 3
- 150000002338 glycosides Chemical class 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 2
- 229960002666 1-octacosanol Drugs 0.000 claims description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- 241000157282 Aesculus Species 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 235000015888 Aralia elata Nutrition 0.000 claims description 2
- 241001632409 Aralia elata Species 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 claims description 2
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 claims description 2
- 235000013912 Ceratonia siliqua Nutrition 0.000 claims description 2
- 240000008886 Ceratonia siliqua Species 0.000 claims description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- 241000749669 Eutrema yunnanense Species 0.000 claims description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 241000270288 Gekko Species 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920002581 Glucomannan Polymers 0.000 claims description 2
- 108010024636 Glutathione Proteins 0.000 claims description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 2
- 241000208253 Gymnema sylvestre Species 0.000 claims description 2
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims description 2
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 2
- 240000000588 Hericium erinaceus Species 0.000 claims description 2
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 2
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 2
- 240000005979 Hordeum vulgare Species 0.000 claims description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 2
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 2
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 2
- 240000008415 Lactuca sativa Species 0.000 claims description 2
- 229920001491 Lentinan Polymers 0.000 claims description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 239000004384 Neotame Substances 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 241000237502 Ostreidae Species 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 2
- 241000220317 Rosa Species 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 102000008114 Selenoproteins Human genes 0.000 claims description 2
- 108010074686 Selenoproteins Proteins 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 235000006468 Thea sinensis Nutrition 0.000 claims description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 2
- 241001506047 Tremella Species 0.000 claims description 2
- 235000013832 Valeriana officinalis Nutrition 0.000 claims description 2
- 244000126014 Valeriana officinalis Species 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- 229930003471 Vitamin B2 Natural products 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 claims description 2
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 2
- 235000020279 black tea Nutrition 0.000 claims description 2
- 235000021324 borage oil Nutrition 0.000 claims description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 2
- 239000004227 calcium gluconate Substances 0.000 claims description 2
- 235000013927 calcium gluconate Nutrition 0.000 claims description 2
- 229960004494 calcium gluconate Drugs 0.000 claims description 2
- 229960002079 calcium pantothenate Drugs 0.000 claims description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 2
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 2
- 239000011651 chromium Substances 0.000 claims description 2
- 229940046374 chromium picolinate Drugs 0.000 claims description 2
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 2
- 229960003624 creatine Drugs 0.000 claims description 2
- 239000006046 creatine Substances 0.000 claims description 2
- 239000013530 defoamer Substances 0.000 claims description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000013601 eggs Nutrition 0.000 claims description 2
- 230000009144 enzymatic modification Effects 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 229960002413 ferric citrate Drugs 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 229960002442 glucosamine Drugs 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 229940087603 grape seed extract Drugs 0.000 claims description 2
- 235000002532 grape seed extract Nutrition 0.000 claims description 2
- 150000003278 haem Chemical class 0.000 claims description 2
- 235000010181 horse chestnut Nutrition 0.000 claims description 2
- 229940089491 hydroxycitric acid Drugs 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 229940097275 indigo Drugs 0.000 claims description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 2
- 229940115286 lentinan Drugs 0.000 claims description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims description 2
- 235000019136 lipoic acid Nutrition 0.000 claims description 2
- 159000000003 magnesium salts Chemical class 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 229940072543 manganese gluconate Drugs 0.000 claims description 2
- 235000014012 manganese gluconate Nutrition 0.000 claims description 2
- 239000011683 manganese gluconate Substances 0.000 claims description 2
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 235000019412 neotame Nutrition 0.000 claims description 2
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 2
- 108010070257 neotame Proteins 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 235000020636 oyster Nutrition 0.000 claims description 2
- 239000003346 palm kernel oil Substances 0.000 claims description 2
- 235000019865 palm kernel oil Nutrition 0.000 claims description 2
- 235000019175 phylloquinone Nutrition 0.000 claims description 2
- 239000011772 phylloquinone Substances 0.000 claims description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 2
- 229960001898 phytomenadione Drugs 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 2
- 239000004172 quinoline yellow Substances 0.000 claims description 2
- 235000012752 quinoline yellow Nutrition 0.000 claims description 2
- 229940051201 quinoline yellow Drugs 0.000 claims description 2
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 claims description 2
- 229940026314 red yeast rice Drugs 0.000 claims description 2
- 235000021283 resveratrol Nutrition 0.000 claims description 2
- 229940016667 resveratrol Drugs 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 229940085605 saccharin sodium Drugs 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- 235000012045 salad Nutrition 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 235000020374 simple syrup Nutrition 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 229950006451 sorbitan laurate Drugs 0.000 claims description 2
- 235000011067 sorbitan monolaureate Nutrition 0.000 claims description 2
- 229950004959 sorbitan oleate Drugs 0.000 claims description 2
- 229940031439 squalene Drugs 0.000 claims description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 229960003080 taurine Drugs 0.000 claims description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 2
- 239000011721 thiamine Substances 0.000 claims description 2
- 229960002663 thioctic acid Drugs 0.000 claims description 2
- 235000016788 valerian Nutrition 0.000 claims description 2
- 235000015192 vegetable juice Nutrition 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 235000019164 vitamin B2 Nutrition 0.000 claims description 2
- 239000011716 vitamin B2 Substances 0.000 claims description 2
- 235000019158 vitamin B6 Nutrition 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 2
- 239000000080 wetting agent Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims 1
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 claims 1
- 241000186000 Bifidobacterium Species 0.000 claims 1
- 206010011224 Cough Diseases 0.000 claims 1
- 244000241257 Cucumis melo Species 0.000 claims 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims 1
- 240000006927 Foeniculum vulgare Species 0.000 claims 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims 1
- 244000197580 Poria cocos Species 0.000 claims 1
- 235000008599 Poria cocos Nutrition 0.000 claims 1
- 241000353135 Psenopsis anomala Species 0.000 claims 1
- 241000220324 Pyrus Species 0.000 claims 1
- 241001145025 Saussurea involucrata Species 0.000 claims 1
- 244000228451 Stevia rebaudiana Species 0.000 claims 1
- 235000009754 Vitis X bourquina Nutrition 0.000 claims 1
- 235000012333 Vitis X labruscana Nutrition 0.000 claims 1
- 235000014787 Vitis vinifera Nutrition 0.000 claims 1
- 240000006365 Vitis vinifera Species 0.000 claims 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims 1
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 claims 1
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229960002737 fructose Drugs 0.000 claims 1
- 229960001031 glucose Drugs 0.000 claims 1
- 229930182478 glucoside Natural products 0.000 claims 1
- 150000008131 glucosides Chemical class 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 229930189775 mogroside Natural products 0.000 claims 1
- 235000021017 pears Nutrition 0.000 claims 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 229960004793 sucrose Drugs 0.000 claims 1
- 235000010930 zeaxanthin Nutrition 0.000 claims 1
- 239000001775 zeaxanthin Substances 0.000 claims 1
- 229940043269 zeaxanthin Drugs 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 19
- 239000003814 drug Substances 0.000 abstract description 18
- 239000007884 disintegrant Substances 0.000 abstract description 15
- 238000005516 engineering process Methods 0.000 abstract description 7
- 239000007916 tablet composition Substances 0.000 abstract description 7
- 238000003860 storage Methods 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000008297 liquid dosage form Substances 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 3
- 230000002035 prolonged effect Effects 0.000 abstract description 3
- 235000009470 Theobroma cacao Nutrition 0.000 abstract 1
- 244000240602 cacao Species 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 66
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 8
- 239000012530 fluid Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- 206010010071 Coma Diseases 0.000 description 3
- 208000019505 Deglutition disease Diseases 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960003511 macrogol Drugs 0.000 description 2
- 229940037627 magnesium lauryl sulfate Drugs 0.000 description 2
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 description 2
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000007909 solid dosage form Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- YCSMVPSDJIOXGN-UHFFFAOYSA-N CCCCCCCCCCCC[Na] Chemical compound CCCCCCCCCCCC[Na] YCSMVPSDJIOXGN-UHFFFAOYSA-N 0.000 description 1
- RZYKUPXRYIOEME-UHFFFAOYSA-N CCCCCCCCCCCC[S] Chemical compound CCCCCCCCCCCC[S] RZYKUPXRYIOEME-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920003091 Methocel™ Polymers 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- AQLLBJAXUCIJSR-UHFFFAOYSA-N OC(=O)C[Na] Chemical compound OC(=O)C[Na] AQLLBJAXUCIJSR-UHFFFAOYSA-N 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 229910003978 SiClx Inorganic materials 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- HGWOWDFNMKCVLG-UHFFFAOYSA-N [O--].[O--].[Ti+4].[Ti+4] Chemical compound [O--].[O--].[Ti+4].[Ti+4] HGWOWDFNMKCVLG-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- WQPDQJCBHQPNCZ-UHFFFAOYSA-N cyclohexa-2,4-dien-1-one Chemical group O=C1CC=CC=C1 WQPDQJCBHQPNCZ-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000008171 pumpkin seed oil Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及一种可快速分散的片剂及其制备方法,尤其涉及一种不含崩解剂、可可快速分散的片剂组合物及其制备工艺,属于药品、保健品领域。本发明公开了一种可快速分散的片剂,由0.5~900重量份活性成分、200~900重量份赋形剂和5~30重量份润滑剂组成,其中活性成分为水不溶性活性成分。本发明的优点是:将含有不溶性活性成分的本发明制备成片剂而非液体剂型,无需将不溶性活性成分制成液体制剂所用的复杂工艺,也克服了该产品液体长期储存过程中会分层的现象,而且具有剂量准确、质量稳定、储存携带方便、可吞服亦可冲服。
Description
技术领域
本发明涉及一种可快速分散的片剂及其制备方法,尤其涉及一种不含崩解剂、可快速分散、含水不溶性活性成分的片剂组合物及其制备工艺,属于药品、保健品领域。
背景技术
目前的医药保健品领域,剂型种类众多,每种剂型都有各自的优缺点。与其他剂型相比,固体剂型有许多优点,应用广泛。固体剂型的剂量准确,药物内含量差异较小;固体剂型为干燥固体,且某些易氧化变质及潮解的药物可借包衣加以保护,所以光线、空气、水分等对其影响较小,质量稳定;机械化生产固体剂,产量大,成本低,卫生标准也容易达到。但是,片剂也有一些缺点。虽然传统片剂和胶囊剂携带、运输、服用较方便,但是药物的溶出速率较溶液剂、散剂慢,其生物利用度稍差些;只适用于吞服,水溶性差无法溶于水后服用,对儿童、吞咽困难的老人和昏迷病人来说服用困难。泡腾片剂只适用于溶于水中服用,病人在没有水的情况下无法服用。散剂可以溶于水,做为液体服用,但是一般不适于吞服,而且携带不方便。
由于不溶性活性成分难溶于水,制备为液体剂型工艺复杂、长期储存有分层问题,而且运输携带均不方便。将不溶性活性成分制备为片剂可以克服这些缺点。传统片剂中含有崩解剂,可快速分散,然而现有的崩解剂多为难溶于水的物质,如果将含有崩解剂的片剂溶于水给儿童、吞咽困难的老人或昏迷病人服用,大量不溶的崩解剂混悬于水中,增加液体的浑浊度,带来不良的用户体验。而不含崩解剂的常用片剂溶解速度慢,不仅达到药效用时长,而且不易溶于水,只利于吞服,不利于儿童、吞咽困难的老人或昏迷病人服用。所以需要制备一种质量稳定、携带运输方便、既可以吞服、又可快速分散于水中做为液体服用的片剂以弥补本领域研究的空白。
发明内容
为了解决上述技术问题,本发明提供一种不含崩解剂、可快速分散的不溶性活性成分的片剂组合物及其制备方法。
一种可快速分散的片剂,由0.5~900重量份活性成分、200~900重量份赋形剂和5~30重量份润滑剂组成,其中活性成分为水不溶性活性成分。
优选的,该片剂由1~600重量份活性成分、500~700重量份赋形剂和10~20重量份润滑剂组成。
优选的,赋形剂选自山梨醇、甘露醇、可溶性淀粉、糊精、微晶纤维素、聚乙二醇、乳糖中的一种或多种;更优选的,赋形剂选自山梨醇、甘露醇、乳糖、糊精中的一种或多种。
优选的,润滑剂选自硬脂酸、微粉化泊洛沙姆、富马硬脂酸钠、聚乙二醇、十二烷基硫酸钠、十二烷基硫酸镁、月桂醇硫酸镁、富马酸中的一种或多种;更优选的,润滑剂选自硬脂酸、聚乙二醇、微粉化泊洛沙姆、富马硬脂酸钠中的一种或多种。
优选的,水不溶性活性成分选自鱼油微囊粉、亚麻籽油微囊粉、奇亚籽油微囊粉、紫苏籽油微囊粉、山茶籽油微囊粉、南瓜籽油微囊粉、月见草油微囊粉、琉璃苣油微囊粉、椰油微囊粉、棕榈仁油微囊粉、沙棘籽油微囊粉、沙棘果油微囊粉、葡萄籽油微囊粉、橄榄油微囊粉、红花籽油微囊粉中的一种或多种。
优选的,水不溶性活性成分选自番茄红素、褪黑素、维生素E、辅酶Q10、蜜环菌提取物、叶黄素、山茶籽提取物、神经节苷脂、芝麻多酚、白藜芦醇、吡啶甲酸铬、二十八醇、胡萝卜色素、红曲、β-胡萝卜素、姜黄、姜黄素、角鲨烯、镁盐、脑磷脂、磷脂酰丝胺酸、神经鞘磷脂、柠檬酸钙、柠檬酸铁铵、天然胡萝卜素、维生素A、维生素D、维生素K1、维生素K2、硒蛋白、富铬酵母、虾青素、血红素铁、富锌酵母、亚麻仁种皮纤维、羊胎素、叶绿素、叶黄素酯、叶酸、玉米黄质、蛤蚧、蜂花粉、绞股蓝、苦瓜、可沙拉希、麦冬、七叶树子、森林匙羹藤、山萮菜、缬草、雪莲、亚麻籽胶、月桂叶、枳椇子、刺老牙、金耳、非变性II型胶原蛋白以及上述原料的微囊粉或包合物中的一种或多种。
更优选的,水不溶性活性成分选自番茄红素、褪黑素、维生素E、姜黄、姜黄素、辅酶Q10、蜜环菌提取物、叶黄素、叶黄素酯、山茶籽提取物、神经节苷脂、芝麻多酚以及上述原料微囊粉或包合物、鱼油微囊粉、亚麻籽油微囊粉、奇亚籽油微囊粉、紫苏籽油微囊粉中的一种或多种。
最优选的,水不溶性活性成分选自辅酶Q10微囊粉、维生素E微囊粉、辅酶Q10包合物、维生素E包合物中的一种或多种。
优选的,一种可快速分散的片剂,还含有5~1050重量份水溶性活性成分,所述水溶性活性成分选自胶原蛋白、左旋肉碱、氨基葡萄糖、维生素C、谷胱甘肽、L-茶氨酸、大麦素、泛酸钙、褐藻胶、红茶多酚、肌醇、角豆胶、卵白肽、酶改性茴香苷、羟基柠檬酸、透明质酸、云芝多糖、N-甲酰酪胺、硫酸软骨素、牛磺酸、葡萄糖酸钙、葡萄糖酸锌、葡萄糖酸锰、葡萄糖亚铁、葡萄籽提取物、维生素B1、维生素B2、维生素B6、维生素B12、葡甘露聚糖、硫辛酸、水溶性低聚糖、壳寡糖、五层龙提取物、三肌酸β-羟基-β-甲基丁酸盐、乳清蛋白、乳酸菌、双歧杆菌、嗜酸乳杆菌、香菇多糖、灵芝多糖、猴头菇多糖、茯苓多糖、银耳多糖、牡蛎肽中的一种或多种。
优选的,一种可快速分散的片剂,还含有0.5~45重量份乳化剂,乳化剂选自十二烷基硫酸钠、蛋黄卵磷脂、泊洛沙姆188、月桂山梨坦、油酸山梨坦、聚山梨酯80、阿拉伯胶、琼脂、蔗糖硬脂酸酯中的一种或多种。
优选的,一种可快速分散的片剂,还含有30~70重量份矫味剂,矫味剂选自甜菊糖苷、阿斯巴甜、三氯蔗糖、糖精钠、甜蜜素、甘草、安赛蜜、阿沙苏法、纽甜、塔格糖、甘草酸二钠、葡萄糖、果糖、蔗糖、木糖醇、单糖浆、果汁糖浆、蜂蜜、甘油、山梨醇、甘露醇、罗汉果甜苷、低聚糖、天然香精、合成香精、天然等同香精、发酵香精、天然果汁粉、天然蔬菜汁粉、蔬菜浓缩汁粉、水果浓缩汁粉、腺苷单磷酸、维生素C、苹果酸、柠檬酸中的一种或多种;更优选的,矫味剂选自甜菊糖苷、阿斯巴甜、三氯蔗糖、甜蜜素、甘草、安赛蜜、天然果汁粉、苹果酸、柠檬酸、低聚糖、天然香精中的一种或多种。
优选的,一种可快速分散的片剂,还含有4~15重量份粘合剂,所述粘合剂选自聚维酮、羟丙基纤维素、羟丙基甲基纤维素、羧甲基纤维素钠、甲基纤维素、乙基纤维素、明胶、卡波姆、淀粉浆中的一种或多种。
优选的,一种可快速分散的片剂,还含有1~15重量份着色剂,所述着色剂选自焦糖色素、红花黄色素、柠檬黄、日落黄、喹啉黄、紫氧化铁、黑氧化铁、棕氧化铁、红氧化铁、黄氧化铁、二氧化钛、靛蓝、叶绿素、胭脂红、亮蓝中的一种或多种。
优选的,一种可快速分散的片剂,还含有3~18重量份包衣剂,所述包衣剂选自蔗糖、成膜性好的高分子聚合物、增塑剂、抗结剂、遮光剂、表面活性剂、色素、消泡剂、光亮剂的一种或多种。
优选的,成膜性好的高分子聚合物选自羟丙基纤维素、羟丙基甲基纤维素、羧甲基纤维素钠、聚乙烯砒咯烷酮、乙基纤维素、甲基纤维素、羟乙基纤维素、甲基羟乙基纤维素、聚乙烯醇中的一种或多种;优选的,增塑剂选自甘油、吐温、聚乙二醇、丙二醇、蓖麻油、邻苯二甲酸二乙酯、柠檬酸三乙脂中的一种或多种;优选的,抗结剂选自滑石粉、硬脂酸镁、二氧化硅、二氧化钛中的一种或多种;优选的,遮光剂选自二氧化钛;表面活性剂选自十二烷基硫酸钠、吐温、油酸、磷脂中的一种或多种。
优选的,该片剂的重量为0.1~2.0克/片;更优选的,片剂重量为0.8~1.5克/片。
优选的,一种可快速分散的片剂的制备方法,其特征在于为下述任一方法:
方法一,
称量所有原料,混合均匀,将混合物置于压片机中,直接压片,制成片剂;
或方法二,
将所有原料过80目筛,称取活性成分、赋形剂、其他辅料后采用干法制粒法、湿法制粒法、一步制粒法中的一种制成颗粒,然后将颗粒与润滑剂混合,压片,制成片剂;
所述干法制粒法,是将称好活性成分、赋形剂、其他辅料混合均匀,将混合物以干法制粒机压成片状或板状,再粉碎成大小合适的颗粒,过筛整粒即可;
所述湿法制粒法,是将称好的活性成分、赋形剂、除粘合剂外的其他辅料放入湿法制粒机容器中混合均匀,喷入粘合剂溶液,粘合剂溶液用量为固体原料总用量的10~15%,物料被制成颗粒;颗粒被送到整粒机中粉碎过大的结块,过筛,然后烘干整粒即得;粘合剂溶液浓度为1%~25%,选用粘合剂水溶液或粘合剂乙醇水溶液;润湿剂选用水或30%~70%乙醇水溶液;
所述一步制粒法,是将称好的活性成分、赋形剂、除粘合剂外的其他辅料放入密闭的流化床内,进行流化使粉末混合均匀;开动喷雾装置,喷入粘合剂水溶液,雾滴在粉体上凝聚,直到所需颗粒尺寸才停止喷雾;最后,将颗粒干燥;粘合剂水溶液浓度为1%~15%,粘合剂水溶液用量为固体原料总用量的10~20%。
所述片剂还可以包衣。
本发明经过大量实验,为本片剂组合物确定了特有的赋形剂和润滑剂,赋形剂优选自山梨醇、甘露醇、可溶性淀粉、糊精、微晶纤维素、聚乙二醇4000、聚乙二醇6000、乳糖中的一种或多种,润滑剂选自硬脂酸、微粉化泊洛沙姆、富马硬脂酸钠、聚乙二醇、十二烷基硫酸钠、十二烷基硫酸镁、月桂醇硫酸镁、富马酸的一种或多种。我们惊奇的发现,在不添加崩解剂的情况下,选用特定的赋形剂和润滑剂组合,药品在水中的分散效果反而更佳。这是因为,常用赋形剂为粘性物质,加入崩解剂后,赋形剂的粘性更强,抑制药品在水中分散。由于本发明能快速分散于水中,可以以液体形式被服用,因此本发明不仅可以吞服,还可以供不易吞服病人分散于水中服用,解决了片剂生物利用度低、难吞服病人无法服用的问题。本发明如需以液体形式服用,临近服药时再分散于水中,将液体摇匀后服用,因为片剂相对于液体制剂更加稳定而且便于携带。本发明制备的片剂组合物除了应用于药品、保健品行业,还可以应用于新兴的功能性食品领域,既可以吞服又可以将片剂分散于水中做为功能性食品饮料饮用,携带和服用均方便。
本发明的优点是:将含有不溶性活性成分的本发明制备成片剂而非液体剂型,无需将不溶性活性成分制成液体制剂所用的复杂工艺,也克服了该产品液体长期储存过程中会分层的现象,而且具有剂量准确、质量稳定、储存携带方便、可吞服亦可冲服等优点。
以下将配合实施例来详细说明本发明的实施方式,藉此对本发明如何应用技术手段来解决技术问题并达成技术功效的实现过程能充分理解并据以实施。凡依照本公开内容进行的本领域等同替换,均属于本发明的保护范围。
具体实施方式
实施例1
一、处方
番茄红素600克;左旋肉碱5克;山梨醇500克;硬脂酸10克;微粉化泊洛沙姆10克;甜蜜素30克;羟丙基纤维素18g;羟丙基甲基纤维素7.2克、乙烯基吡咯烷酮1克、甘油1.8克、吐温1克、二氧化钛0.6克、色素0.5克。
二、制备方法
将番茄红素、左旋肉碱、山梨醇、甜蜜素过80目筛,按配方称取过筛后的原料放入密闭的流化床内,进行流化使粉末混合均匀。开动喷雾装置,喷入羟丙基纤维素水溶液(浓度为15%),雾滴在粉体上凝聚,直到所需颗粒尺寸为20目停止喷雾。最后,将颗粒干燥。然后将颗粒与硬脂酸、微粉化泊洛沙姆混合,调节压片机的片重为1.5克,直接压片制成片剂,再将片剂包上包衣粉(包衣粉由羟丙基甲基纤维素、乙烯基吡咯烷酮、甘油、吐温、二氧化钛、色素组成)。
实施例2
一、处方
叶黄素8克;维生素E 400克;山梨醇600克;硬脂酸15克;蔗糖45.5克。
二、制备方法
按配方称取叶黄素、维生素E、山梨醇、硬脂酸并混合均匀,将混合物置于压片机中,调节片重为1.5克后,直接压片,制成片剂后,包裹糖衣。
实施例3
一、处方
褪黑素1克;甘露醇700克;硬脂酸20克;聚维酮11.5克。
二、制备方法
将褪黑素、甘露醇过80目筛,按配方称取过筛后的原料将称好的原料放入湿法制粒机容器中混合均匀,喷入聚维酮水溶液(聚维酮水溶液浓度为10%),同时物料被强力搅拌并被切割刀切碎成颗粒。颗粒被送到整粒机中粉碎过大的结块,过20目筛,然后送入流化床中烘干即得颗粒。然后将颗粒与硬脂酸混合,调节压片机的片重为0.8克,直接压片,制成片剂。
实施例4
一、处方
维生素D 300克;虾青素0.5克;山梨醇500克;可溶性淀粉400克;微粉化泊洛沙姆30克;聚维酮12.5g。
二、制备方法
将维生素D、虾青素、山梨醇、可溶性淀粉过80目筛,按配方称取过筛后的原料放入密闭的流化床内,进行流化使粉末混合均匀。开动喷雾装置,喷入聚维酮水溶液(聚维酮水溶液浓度为5%),雾滴在粉体上凝聚,直到所需颗粒尺寸为20目才停止喷雾。最后,将颗粒干燥。然后将颗粒与微粉化泊洛沙姆混合,调节压片机的片重为0.1克,直接压片,制成片剂。
实施例5
一、处方
姜黄素12克;山梨醇200克;硬脂酸5克;甜菊糖苷15克。
二、制备方法
按配方称取姜黄素、山梨醇、硬脂酸、甜菊糖苷并混合均匀,将混合物置于压片机中,调节片重为1.0克后,直接压片,制成片剂。
实施例6
一、处方
麦冬900克;山梨醇500克;硬脂酸10克;柠檬黄0.2g。
二、制备方法
将麦冬、山梨醇、柠檬黄过80目筛,按配方称取过筛后的原料加入干法制粒机中混合均匀,将混合物压成片状或板状,再粉碎成大小合适的颗粒,过40目筛整粒;然后将颗粒与硬脂酸混合,调节压片机的片重为0.8克,直接压片,制成片剂。
实施例7
一、处方
辅酶Q10微囊粉500克;山梨醇600克;硬脂酸15克;阿斯巴甜20克;羟丙基甲基纤维素29g;十二烷基硫酸钠0.5g。
二、制备方法
将辅酶Q10微囊粉、山梨醇、阿斯巴甜、十二烷基硫酸钠过80目筛,按配方称取过筛后的原料放入密闭的流化床内,进行流化使粉末混合均匀。开动喷雾装置,喷入羟丙基甲基纤维素水溶液(浓度为15%),雾滴在粉体上凝聚,直到所需颗粒尺寸为20目才停止喷雾。最后,将颗粒干燥。然后将颗粒与硬脂酸混合,调节压片机的片重为1.0克,直接压片,制成片剂。
实施例8
一、处方
羊胎素100克;可溶性淀粉500克;富马硬脂酸钠5克;甜菊糖苷20克;焦糖色素30克。
二、制备方法
将羊胎素、可溶性淀粉、甜菊糖苷、焦糖色素过80目筛,按配方称取过筛后的原料加入干法制粒机中混合均匀,将混合物压成片状或板状,再粉碎成大小合适的颗粒,过40目筛整粒即可。然后将颗粒与福马硬脂酸钠混合,调节压片机的片重为2.0克,直接压片,制成片剂。
实施例9
一、处方
柠檬酸钙200克;山梨醇900克;硬脂酸30克;阿斯巴甜40克。
二、制备方法
将柠檬酸钙、山梨醇、阿斯巴甜过80目筛,按配方称取过筛后的原料将称好的原料放入湿法制粒机容器中混合均匀,喷入30%乙醇水溶液(乙醇水溶液用量为固体原料用量的25%),同时物料被强力搅拌并被切割刀切碎成颗粒。颗粒被送到整粒机中粉碎过大的结块,过20目筛,然后送入流化床中烘干即得颗粒。然后将颗粒与硬脂酸混合,调节压片机的片重为1克,直接压片,制成片剂。
对照例1
一、处方
辅酶Q10 500克;山梨醇100克;硬脂酸10克;阿斯巴甜20克;羟丙基甲基纤维素17g。
二、制备方法
将辅酶Q10、山梨醇、阿斯巴甜过80目筛,按配方称取过筛后的原料放入密闭的流化床内,进行流化使粉末混合均匀。开动喷雾装置,喷入羟丙基甲基纤维素水溶液(浓度为15%),雾滴在粉体上凝聚,直到所需颗粒尺寸为20目才停止喷雾。最后,将颗粒干燥。然后将颗粒与硬脂酸混合,调节压片机的片重为1.0克,直接压片,制成片剂。
对照例2
一、处方
辅酶Q10500克;糊精600克;硬脂酸镁15克;阿斯巴甜20克;羟丙基甲基纤维素29g。
二、制备方法
将辅酶Q10、糊精、阿斯巴甜过80目筛,按配方称取过筛后的原料放入密闭的流化床内,进行流化使粉末混合均匀。开动喷雾装置,喷入羟丙基甲基纤维素水溶液(浓度为15%),雾滴在粉体上凝聚,直到所需颗粒尺寸为20目才停止喷雾。最后,将颗粒干燥。然后将颗粒与硬脂酸镁混合,调节压片机的片重为1.0克,直接压片,制成片剂。
对照例3
一、处方
辅酶Q10 500克;山梨醇600克;硬脂酸15克;羧甲基淀粉钠78克;阿斯巴甜20克;羟丙基甲基纤维素29g。
二、制备方法
将辅酶Q10、山梨醇、羧甲基淀粉钠、阿斯巴甜过80目筛,按配方称取过筛后的原料放入密闭的流化床内,进行流化使粉末混合均匀。开动喷雾装置,喷入羟丙基甲基纤维素水溶液(浓度为15%),雾滴在粉体上凝聚,直到所需颗粒尺寸为20目才停止喷雾。最后,将颗粒干燥。然后将颗粒与硬脂酸混合,调节压片机的片重为1.0克,直接压片,制成片剂。
物理性能检测实验
一、受试药品
1、本发明实施例1至实施例9药物。
2、对比药物:对照例1至对照例3药物。
二、测试方法
崩解时限检测方法:根据《中国药典2010版第二部附录XA崩解时限检查法》测定样品的崩解时限。采用升降式崩解仪,将吊篮(其中筛网的筛孔内径为2.0mm)通过上端的不锈钢轴悬挂于金属支架上,浸入1000ml烧杯中,并调节吊篮位置使其下降时筛网距烧杯底部25mm,烧杯内盛有温度为37±1℃的水,调节液面高度使吊篮上升时筛网在液面下15mm处。取供试品6片,分别置上述吊篮的玻璃管中,每管各加1片,立即启动崩解仪进行检查。各片均应在5分钟内全部崩解,记录崩解时限。如有1片不能完全崩解,应另取6片复试,均应符合规定。
三、实验结果
表1记录了实施例和对照例的崩解时限的检测结果。
表1实施例和对照例样品的崩解时限
| 样品 | 崩解时限(秒) |
| 实施例1 | 395 |
| 实施例2 | 351 |
| 实施例3 | 340 |
| 实施例4 | 419 |
| 实施例5 | 312 |
| 实施例6 | 407 |
| 实施例7 | 305 |
| 实施例8 | 376 |
| 实施例9 | 338 |
| 对照例1 | >3600 |
| 对照例2 | 927 |
| 对照例3 | 427 |
观察实施例和对照例的崩解时限数据,9个实施例的崩解时限为305秒~419秒。3个对照例的崩解时限均大于各实施例的崩解时限,对照例1大于3600秒,对照例2为927秒,对照例3为427秒。实施例1~9不含崩解剂,选用特定的赋形剂和润滑剂组合;对照例1不含崩解剂,含本发明保护的赋形剂和润滑剂,其中赋形剂使用剂量超出本发明的用量范围;对照例2不含崩解剂,赋形剂和润滑剂的用量均不在本发明保护范围内;对照例3含有崩解剂、赋形剂和润滑剂。通过分析这些数据可知,本发明实施例样品的溶出速度快,配方优良。
本发明将含有不溶性活性成分的本发明制备成片剂而非液体剂型,无需将不溶性活性成分制成液体制剂所用的复杂工艺,也克服了该产品液体长期储存过程中会分层的现象,而且具有剂量准确、质量稳定、储存携带方便、可吞服也可冲服等优点。经过大量实验,本片剂组合物确定了特有的赋形剂和润滑剂,赋形剂优选自山梨醇、甘露醇、可溶性淀粉、糊精、微晶纤维素、聚乙二醇4000、聚乙二醇6000、乳糖中的一种或多种;润滑剂选自硬脂酸、微粉化泊洛沙姆、富马硬脂酸钠、聚乙二醇、十二烷基硫酸钠、十二烷基硫酸镁、月桂醇硫酸镁、富马酸的一种或多种中的一种或多种。我们惊奇的发现,在不添加崩解剂的情况下,选用特定的赋形剂和润滑剂组合,药品在水中的分散效果反而更佳。这是因为,本发明的赋形剂为粘性物质,加入崩解剂后,该类赋形剂的粘性更强,抑制药品在水中分散。由于本发明能快速分散于水中,可以以液体形式被服用,因此本发明不仅可以吞服,还可以供不易吞服病人分散于水中服用,解决了片剂生物利用度低、难吞服病人无法服用的问题。本发明如需以液体形式服用,临近服药时再分散于水中,将液体摇匀后服用,因为片剂相对于液体制剂更加稳定而且便于携带。本发明制备的片剂组合物除了应用于药品、保健品行业,还可以应用于新兴的功能性食品领域,既可以吞服又可以将片剂分散于水中做为功能性食品饮料饮用,携带和服用均方便。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (25)
1.一种可快速分散的片剂,其特征在于:由0.5~900重量份活性成分、200~900重量份赋形剂和5~30重量份润滑剂组成,其中活性成分为水不溶性活性成分。
2.根据权利要求1所述的一种可快速分散的片剂,其特征在于:所述片剂由1~600重量份活性成分、500~700重量份赋形剂和10~20重量份润滑剂组成。
3.根据权利要求1或2所述的一种可快速分散的片剂,其特征在于:所述赋形剂选自山梨醇、甘露醇、可溶性淀粉、糊精、微晶纤维素、聚乙二醇、乳糖中的一种或多种。
4.根据权利要求3所述的一种可快速分散的片剂,其特征在于:所述赋形剂为山梨醇、甘露醇、乳糖、糊精中的一种或多种。
5.根据权利要求1或2所述的一种可快速分散的片剂,其特征在于:所述润滑剂选自硬脂酸、微粉化泊洛沙姆、富马硬脂酸钠、聚乙二醇、十二烷基硫酸钠、十二烷基硫酸镁、月桂醇硫酸镁、富马酸中的一种或多种。
6.根据权利要求5所述的一种可快速分散的片剂,其特征在于:所述润滑剂为硬脂酸、聚乙二醇、微粉化泊洛沙姆、富马硬脂酸钠中的一种或多种。
7.根据权利要求1所述的一种可快速分散的片剂,其特征在于:所述水不溶性活性成分选自鱼油微囊粉、亚麻籽油微囊粉、奇亚籽油微囊粉、紫苏籽油微囊粉、山茶籽油微囊粉、南瓜籽油微囊粉、月见草油微囊粉、琉璃苣油微囊粉、椰油微囊粉、棕榈仁油微囊粉、沙棘籽油微囊粉、沙棘果油微囊粉、葡萄籽油微囊粉、橄榄油微囊粉、红花籽油微囊粉中的一种或多种。
8.根据权利要求1所述的一种可快速分散的片剂,其特征在于:所述水不溶性活性成分选自番茄红素、褪黑素、维生素E、辅酶Q10、蜜环菌提取物、叶黄素、山茶籽提取物、神经节苷脂、芝麻多酚、白藜芦醇、吡啶甲酸铬、二十八醇、胡萝卜色素、红曲、β-胡萝卜素、姜黄、姜黄素、角鲨烯、镁盐、脑磷脂、磷脂酰丝胺酸、神经鞘磷脂、柠檬酸钙、柠檬酸铁铵、天然胡萝卜素、维生素A、维生素D、维生素K1、维生素K2、硒蛋白、富铬酵母、虾青素、血红素铁、富锌酵母、亚麻仁种皮纤维、羊胎素、叶绿素、叶黄素酯、叶酸、玉米黄质、蛤蚧、蜂花粉、绞股蓝、苦瓜、可沙拉希、麦冬、七叶树子、森林匙羹藤、山萮菜、缬草、雪莲、亚麻籽胶、月桂叶、枳椇子、刺老牙、金耳、非变性II型胶原蛋白以及上述原料的微囊粉或包合物中的一种或多种。
9.根据权利要求7或8所述的一种可快速分散的片剂,其特征在于:所述水不溶性活性成分选自番茄红素、褪黑素、维生素E、姜黄、姜黄素、辅酶Q10、蜜环菌提取物、叶黄素、叶黄素酯、山茶籽提取物、神经节苷脂、芝麻多酚以及上述原料微囊粉或包合物、鱼油微囊粉、亚麻籽油微囊粉、奇亚籽油微囊粉、紫苏籽油微囊粉中的一种或多种。
10.根据权利要求9所述的一种可快速分散的片剂,其特征在于:所述水不溶性活性成分选自辅酶Q10微囊粉、维生素E微囊粉、辅酶Q10包合物、维生素E包合物中的一种或多种。
11.根据权利要求1-10所述的一种可快速分散的片剂,其特征在于:还含有5~1050重量份水溶性活性成分,所述水溶性活性成分选自胶原蛋白、左旋肉碱、氨基葡萄糖、维生素C、谷胱甘肽、L-茶氨酸、大麦素、泛酸钙、褐藻胶、红茶多酚、肌醇、角豆胶、卵白肽、酶改性茴香苷、羟基柠檬酸、透明质酸、云芝多糖、N-甲酰酪胺、硫酸软骨素、牛磺酸、葡萄糖酸钙、葡萄糖酸锌、葡萄糖酸锰、葡萄糖亚铁、葡萄籽提取物、维生素B1、维生素B2、维生素B6、维生素B12、葡甘露聚糖、硫辛酸、水溶性低聚糖、壳寡糖、五层龙提取物、三肌酸β-羟基-β-甲基丁酸盐、乳清蛋白、乳酸菌、双歧杆菌、嗜酸乳杆菌、香菇多糖、灵芝多糖、猴头菇多糖、茯苓多糖、银耳多糖、牡蛎肽中的一种或多种。
12.根据权利要求1至11中任何一项所述的一种可快速分散的片剂,其特征在于:还含有0.5~45重量份乳化剂,所述的乳化剂选自十二烷基硫酸钠、蛋黄卵磷脂、泊洛沙姆188、月桂山梨坦、油酸山梨坦、聚山梨酯80、阿拉伯胶、琼脂、蔗糖硬脂酸酯中的一种或多种。
13.根据权利要求1至11中任何一项所述的一种可快速分散的片剂,其特征在于:还含有30~70重量份矫味剂,所述矫味剂选自甜菊糖苷、阿斯巴甜、三氯蔗糖、糖精钠、甜蜜素、甘草、安赛蜜、阿沙苏法、纽甜、塔格糖、甘草酸二钠、葡萄糖、果糖、蔗糖、木糖醇、单糖浆、果汁糖浆、蜂蜜、甘油、山梨醇、甘露醇、罗汉果甜苷、低聚糖、天然香精、合成香精、天然等同香精、发酵香精、天然果汁粉、天然蔬菜汁粉、蔬菜浓缩汁粉、水果浓缩汁粉、腺苷单磷酸、维生素C、苹果酸、柠檬酸中的一种或多种。
14.根据权利要求13所述的一种可快速分散的片剂,其特征在于:所述矫味剂选自甜菊糖苷、阿斯巴甜、三氯蔗糖、甜蜜素、甘草、安赛蜜、天然果汁粉、苹果酸、柠檬酸、低聚糖、天然香精中的一种或多种。
15.根据权利要求1至11中任何一项所述的一种可快速分散的片剂,其特征在于:还含有4~15重量份粘合剂,所述粘合剂选自聚维酮、羟丙基纤维素、羟丙基甲基纤维素、羧甲基纤维素钠、甲基纤维素、乙基纤维素、明胶、卡波姆、淀粉浆中的一种或多种。
16.根据权利要求1至11中任何一项所述的一种可快速分散的片剂,其特征在于:还含有1~15重量份着色剂,所述着色剂选自焦糖色素、红花黄色素、柠檬黄、日落黄、喹啉黄、紫氧化铁、黑氧化铁、棕氧化铁、红氧化铁、黄氧化铁、二氧化钛、靛蓝、叶绿素、胭脂红、亮蓝中的一种或多种。
17.根据权利要求1至11中任何一项所述的一种可快速分散的片剂,其特征在于:还含有3~18重量份包衣剂,所述包衣剂选自蔗糖、成膜性好的高分子聚合物、增塑剂、抗结剂、遮光剂、表面活性剂、色素、消泡剂、光亮剂的一种或多种。
18.根据权利要求15所述的一种含有胶原蛋白的组合物,其特征在于:所述的成膜性好的高分子聚合物选自羟丙基纤维素、羟丙基甲基纤维素、羧甲基纤维素钠、聚乙烯砒咯烷酮、乙基纤维素、甲基纤维素、羟乙基纤维素、甲基羟乙基纤维素、聚乙烯醇中的一种或多种。
19.根据权利要求17所述的一种含有胶原蛋白的组合物,其特征在于:所述的增塑剂选自甘油、吐温、聚乙二醇、丙二醇、蓖麻油、邻苯二甲酸二乙酯、柠檬酸三乙脂中的一种或多种。
20.根据权利要求17所述的一种含有胶原蛋白的组合物,其特征在于:所述的抗结剂选自滑石粉、硬脂酸镁、二氧化硅、二氧化钛中的一种或多种。
21.根据权利要求17所述的一种含有胶原蛋白的组合物,其特征在于:所述的遮光剂选自二氧化钛。
22.根据权利要求17所述的一种含有胶原蛋白的组合物,其特征在于:所述的表面活性剂选自十二烷基硫酸钠、吐温、油酸、磷脂中的一种或多种。
23.根据权利要求1至22中任何一项所述的一种可快速分散的片剂,其特征在于:所述片剂的重量为0.1~2.0克/片。
24.根据权利要求23所述的一种可快速分散的片剂,其特征在于:所述片剂的重量为0.8~1.5克/片。
25.权利要求1至24中任何一项所述的一种可快速分散的片剂的制备方法,其特征在于为下述任一方法:
方法一,
称量所有原料,混合均匀,将混合物置于压片机中,直接压片,制成片剂;
或方法二,
将所有原料过80目筛,称取活性成分、赋形剂、其他辅料后采用干法制粒法、湿法制粒法、一步制粒法中的一种制成颗粒,然后将颗粒与润滑剂混合,压片,制成片剂;
所述干法制粒法,是将称好活性成分、赋形剂、其他辅料混合均匀,将混合物以干法制粒机压成片状或板状,再粉碎成大小合适的颗粒,过筛整粒即可;
所述湿法制粒法,是将称好的活性成分、赋形剂、除粘合剂外的其他辅料放入湿法制粒机容器中混合均匀,喷入粘合剂溶液,粘合剂溶液用量为固体原料总用量的10~15%,物料被制成颗粒;颗粒被送到整粒机中粉碎过大的结块,过筛,然后烘干整粒即得;粘合剂溶液浓度为1%~25%,选用粘合剂水溶液或粘合剂乙醇水溶液;润湿剂选用水或30%~70%乙醇水溶液;
所述一步制粒法,是将称好的活性成分、赋形剂、除粘合剂外的其他辅料放入密闭的流化床内,进行流化使粉末混合均匀;开动喷雾装置,喷入粘合剂水溶液,雾滴在粉体上凝聚,直到所需颗粒尺寸才停止喷雾;最后,将颗粒干燥;粘合剂水溶液浓度为1%~15%,粘合剂水溶液用量为固体原料总用量的10~20%。
所述片剂还可以包衣。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711012205.1A CN107823150A (zh) | 2017-10-25 | 2017-10-25 | 一种可快速分散的片剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711012205.1A CN107823150A (zh) | 2017-10-25 | 2017-10-25 | 一种可快速分散的片剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107823150A true CN107823150A (zh) | 2018-03-23 |
Family
ID=61649410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711012205.1A Pending CN107823150A (zh) | 2017-10-25 | 2017-10-25 | 一种可快速分散的片剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107823150A (zh) |
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108815269A (zh) * | 2018-07-03 | 2018-11-16 | 郑州博凯医药保健品有限公司 | 叶酸葡萄糖酸亚铁维生素c泡腾片及其制备方法和应用 |
| CN109010805A (zh) * | 2018-09-03 | 2018-12-18 | 北京素维生物科技有限公司 | 一种含ⅱ型胶原蛋白的组合物及其制备工艺 |
| CN109007225A (zh) * | 2018-10-16 | 2018-12-18 | 云南爱尔康生物技术有限公司 | 一种褐藻虾青素压片糖果及其制备方法 |
| CN109156692A (zh) * | 2018-07-20 | 2019-01-08 | 合肥英特美乐生物科技有限公司 | 一种混合天然产物的泡腾片及其制备方法 |
| CN109645529A (zh) * | 2019-02-21 | 2019-04-19 | 湖北人缘堂医药生物工程有限公司 | 一种食丸的制备方法 |
| CN110250459A (zh) * | 2018-08-10 | 2019-09-20 | 江汉大学 | 一种白菜冻干粉片剂及其制备方法和应用 |
| CN110384720A (zh) * | 2018-04-17 | 2019-10-29 | 西南民族大学 | 一种沙棘组合物及其制备方法和用途 |
| CN110507617A (zh) * | 2019-09-06 | 2019-11-29 | 常州大学 | 二甲基姜黄素固体分散体、二甲基姜黄素固体分散片剂及其制备方法 |
| CN111249326A (zh) * | 2020-03-10 | 2020-06-09 | 嘉应学院医学院 | 一种绞股蓝维e口含片及其制备方法 |
| CN112336711A (zh) * | 2020-11-13 | 2021-02-09 | 迪沙药业集团有限公司 | 一种赖氨葡锌口腔崩解片 |
| CN112370429A (zh) * | 2019-10-21 | 2021-02-19 | 广州富诺营养科技有限公司 | 一种直压型有机钙维生素d3咀嚼片及其制备方法 |
| CN112546015A (zh) * | 2020-12-29 | 2021-03-26 | 哈尔滨瀚钧现代制药有限公司 | 一种卵磷脂泡腾片及其制备方法 |
| CN112754021A (zh) * | 2021-01-28 | 2021-05-07 | 乐文堂(青岛)大健康产业集团有限公司 | 一种植物含硒牛骨髓肽复合片及其制备方法 |
| CN113974171A (zh) * | 2021-11-08 | 2022-01-28 | 北京素维生物科技有限公司 | 一种微水快溶组合物、微水快溶食品或药品以及其制备方法 |
| CN114098080A (zh) * | 2021-11-18 | 2022-03-01 | 山东沛学生物工程有限公司 | 一种含透明质酸与叶黄素酯的泡腾片及其在酒产品中的应用 |
| CN114246834A (zh) * | 2021-12-30 | 2022-03-29 | 宣城柏维力生物工程有限公司 | 一种改善睡眠褪黑素口崩制剂及其生产工艺 |
| CN114404576A (zh) * | 2022-03-31 | 2022-04-29 | 深圳德荫堂生物科技有限公司 | 一种安神助眠的药物及生产方法 |
| CN115212206A (zh) * | 2022-08-15 | 2022-10-21 | 江苏知原药业股份有限公司 | 一种含吡非尼酮的药物组合物及其制备方法 |
| CN115315190A (zh) * | 2020-01-24 | 2022-11-08 | 摩茶有限公司 | 饮料合成物 |
| CN115517366A (zh) * | 2022-11-02 | 2022-12-27 | 宝健(北京)生物技术有限公司 | 一种缩短崩解时限和减缓β-胡萝卜素衰减的螺旋藻片剂及其制备方法 |
| IT202100019619A1 (it) * | 2021-07-23 | 2023-01-23 | Apalasol S R L | Uso di una formulazione a base acquosa per potenziare le prestazioni sportive e olfattive degli animali |
| WO2023088962A1 (en) * | 2021-11-16 | 2023-05-25 | Dsm Ip Assets B.V. | Granule comprising encapsulated active ingredients |
| CN119385957A (zh) * | 2024-10-29 | 2025-02-07 | 广东润和生物科技有限公司 | 一种高生物利用度的辅酶q10的片剂及其制备方法 |
| CN120305294A (zh) * | 2025-06-18 | 2025-07-15 | 四川省肿瘤医院 | 一种双层涂层益生菌复合物及其制备方法和用途 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102764254A (zh) * | 2012-05-16 | 2012-11-07 | 深圳信立泰药业股份有限公司 | 一种左乙拉西坦药物组合物及其制备方法 |
| CN103142494A (zh) * | 2013-03-19 | 2013-06-12 | 河北凯盛医药科技有限公司 | 奥硝唑口服制剂及其制备方法 |
| CN104470519A (zh) * | 2012-07-11 | 2015-03-25 | 泰华制药工业有限公司 | 不含碱化剂的拉喹莫德调配物 |
| CN106619646A (zh) * | 2016-11-03 | 2017-05-10 | 江苏恒瑞医药股份有限公司 | 一种替吉奥组合物的制备方法 |
| CN106943367A (zh) * | 2016-01-06 | 2017-07-14 | 山东新时代药业有限公司 | 一种马来酸阿法替尼片及其制备方法 |
-
2017
- 2017-10-25 CN CN201711012205.1A patent/CN107823150A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102764254A (zh) * | 2012-05-16 | 2012-11-07 | 深圳信立泰药业股份有限公司 | 一种左乙拉西坦药物组合物及其制备方法 |
| CN104470519A (zh) * | 2012-07-11 | 2015-03-25 | 泰华制药工业有限公司 | 不含碱化剂的拉喹莫德调配物 |
| CN103142494A (zh) * | 2013-03-19 | 2013-06-12 | 河北凯盛医药科技有限公司 | 奥硝唑口服制剂及其制备方法 |
| CN106943367A (zh) * | 2016-01-06 | 2017-07-14 | 山东新时代药业有限公司 | 一种马来酸阿法替尼片及其制备方法 |
| CN106619646A (zh) * | 2016-11-03 | 2017-05-10 | 江苏恒瑞医药股份有限公司 | 一种替吉奥组合物的制备方法 |
Cited By (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110384720A (zh) * | 2018-04-17 | 2019-10-29 | 西南民族大学 | 一种沙棘组合物及其制备方法和用途 |
| CN108815269A (zh) * | 2018-07-03 | 2018-11-16 | 郑州博凯医药保健品有限公司 | 叶酸葡萄糖酸亚铁维生素c泡腾片及其制备方法和应用 |
| CN109156692A (zh) * | 2018-07-20 | 2019-01-08 | 合肥英特美乐生物科技有限公司 | 一种混合天然产物的泡腾片及其制备方法 |
| CN110250459A (zh) * | 2018-08-10 | 2019-09-20 | 江汉大学 | 一种白菜冻干粉片剂及其制备方法和应用 |
| CN109010805A (zh) * | 2018-09-03 | 2018-12-18 | 北京素维生物科技有限公司 | 一种含ⅱ型胶原蛋白的组合物及其制备工艺 |
| CN109007225A (zh) * | 2018-10-16 | 2018-12-18 | 云南爱尔康生物技术有限公司 | 一种褐藻虾青素压片糖果及其制备方法 |
| CN109645529A (zh) * | 2019-02-21 | 2019-04-19 | 湖北人缘堂医药生物工程有限公司 | 一种食丸的制备方法 |
| CN109645529B (zh) * | 2019-02-21 | 2021-08-06 | 湖北人缘堂医药生物工程有限公司 | 一种食丸的制备方法 |
| CN110507617A (zh) * | 2019-09-06 | 2019-11-29 | 常州大学 | 二甲基姜黄素固体分散体、二甲基姜黄素固体分散片剂及其制备方法 |
| CN112370429A (zh) * | 2019-10-21 | 2021-02-19 | 广州富诺营养科技有限公司 | 一种直压型有机钙维生素d3咀嚼片及其制备方法 |
| CN115315190A (zh) * | 2020-01-24 | 2022-11-08 | 摩茶有限公司 | 饮料合成物 |
| CN111249326A (zh) * | 2020-03-10 | 2020-06-09 | 嘉应学院医学院 | 一种绞股蓝维e口含片及其制备方法 |
| CN111249326B (zh) * | 2020-03-10 | 2021-12-24 | 嘉应学院 | 一种绞股蓝维e口含片及其制备方法 |
| CN112336711A (zh) * | 2020-11-13 | 2021-02-09 | 迪沙药业集团有限公司 | 一种赖氨葡锌口腔崩解片 |
| CN112336711B (zh) * | 2020-11-13 | 2021-09-14 | 迪沙药业集团有限公司 | 一种赖氨葡锌口腔崩解片 |
| CN112546015A (zh) * | 2020-12-29 | 2021-03-26 | 哈尔滨瀚钧现代制药有限公司 | 一种卵磷脂泡腾片及其制备方法 |
| CN112754021A (zh) * | 2021-01-28 | 2021-05-07 | 乐文堂(青岛)大健康产业集团有限公司 | 一种植物含硒牛骨髓肽复合片及其制备方法 |
| IT202100019619A1 (it) * | 2021-07-23 | 2023-01-23 | Apalasol S R L | Uso di una formulazione a base acquosa per potenziare le prestazioni sportive e olfattive degli animali |
| CN113974171A (zh) * | 2021-11-08 | 2022-01-28 | 北京素维生物科技有限公司 | 一种微水快溶组合物、微水快溶食品或药品以及其制备方法 |
| WO2023088962A1 (en) * | 2021-11-16 | 2023-05-25 | Dsm Ip Assets B.V. | Granule comprising encapsulated active ingredients |
| CN114098080A (zh) * | 2021-11-18 | 2022-03-01 | 山东沛学生物工程有限公司 | 一种含透明质酸与叶黄素酯的泡腾片及其在酒产品中的应用 |
| CN114098080B (zh) * | 2021-11-18 | 2024-03-29 | 山东沛学生物工程有限公司 | 一种含透明质酸与叶黄素酯的泡腾片及其在酒产品中的应用 |
| CN114246834A (zh) * | 2021-12-30 | 2022-03-29 | 宣城柏维力生物工程有限公司 | 一种改善睡眠褪黑素口崩制剂及其生产工艺 |
| CN114404576A (zh) * | 2022-03-31 | 2022-04-29 | 深圳德荫堂生物科技有限公司 | 一种安神助眠的药物及生产方法 |
| CN115212206A (zh) * | 2022-08-15 | 2022-10-21 | 江苏知原药业股份有限公司 | 一种含吡非尼酮的药物组合物及其制备方法 |
| CN115212206B (zh) * | 2022-08-15 | 2023-04-18 | 江苏知原药业股份有限公司 | 一种含吡非尼酮的药物组合物及其制备方法 |
| CN115517366A (zh) * | 2022-11-02 | 2022-12-27 | 宝健(北京)生物技术有限公司 | 一种缩短崩解时限和减缓β-胡萝卜素衰减的螺旋藻片剂及其制备方法 |
| CN115517366B (zh) * | 2022-11-02 | 2024-04-02 | 宝健(北京)生物技术有限公司 | 一种缩短崩解时限和减缓β-胡萝卜素衰减的螺旋藻片剂及其制备方法 |
| CN119385957A (zh) * | 2024-10-29 | 2025-02-07 | 广东润和生物科技有限公司 | 一种高生物利用度的辅酶q10的片剂及其制备方法 |
| CN119385957B (zh) * | 2024-10-29 | 2025-11-04 | 广东润和生物科技有限公司 | 一种高生物利用度的辅酶q10的片剂及其制备方法 |
| CN120305294A (zh) * | 2025-06-18 | 2025-07-15 | 四川省肿瘤医院 | 一种双层涂层益生菌复合物及其制备方法和用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107823150A (zh) | 一种可快速分散的片剂及其制备方法 | |
| Zanoni et al. | Microencapsulation by spray-drying of polyphenols extracted from red chicory and red cabbage: Effects on stability and color properties | |
| Adiba et al. | Preliminary characterization of food tablets from date (Phoenix dactylifera L.) and spirulina (Spirulina sp.) powders | |
| CN107823168A (zh) | 一种快速溶解的片剂及其制备方法 | |
| Damasceno et al. | Effect of Bauhinia forficata extract in diabetic pregnant rats: maternal repercussions | |
| Yingngam et al. | Modeling and stability study of the anthocyanin-rich maoberry fruit extract in the fast-dissolving spray-dried microparticles | |
| CN108402465A (zh) | 一种含有异味油类的微囊粉组合物以及其制备工艺 | |
| CN102686676B (zh) | 姜黄色素组合物及其制备方法 | |
| US20110207683A1 (en) | Natural colorant and methods thereof | |
| JP2021004358A (ja) | セルロース粉末、その使用および錠剤 | |
| BR112012033806B1 (pt) | Composição na forma de partícula compreendendo polímero hidrofóbico e composto fenólico, método para preparação da composição e uso da composição | |
| JP2008208118A (ja) | ツルニンジン属植物抽出物含有粉末組成物 | |
| KR20160098906A (ko) | 블루베리 열매 추출물을 함유한 발포정의 제조방법 | |
| TWI465237B (zh) | 神經芽細胞增殖促進劑及神經突起伸展劑 | |
| US10363225B2 (en) | Non-bleeding bioactive natural pigments which prevent color and dust explosions, method of preparation thereof | |
| Kochubei et al. | Optimization of microencapsulation of green tea extract for functional beverage development | |
| JP2018002695A (ja) | 結晶セルロース混合粉末、組成物、及び成形体の製造方法 | |
| CN105533742B (zh) | 一种青海三刺多糖组合物及泡腾片剂和用途 | |
| KR20200089040A (ko) | 미선나무 추출물을 유효성분으로 함유하는 암의 예방, 개선 또는 치료용 조성물 | |
| KR102203209B1 (ko) | 극저온 초미세 분쇄를 이용한 항산화 식물 분말의 과립화 방법 | |
| do Nascimento Remigio et al. | Spray-Drying Microencapsulation of Phenolic Compounds from Bauhinia ungulata L. Var. Obtusifolia Aqueous Extract: A Comparative Study Using Different Wall Materials | |
| CN113785982B (zh) | 一种航天用抗疲劳、抗辐射胶囊及其制备方法 | |
| CN100411635C (zh) | 一种保健品片剂及其制备和应用 | |
| JP3235825U (ja) | 肌の保湿を助け、抗酸化生物活性物質を有する粒子構造 | |
| Ghellam et al. | Capacity of hazelnut cake to produce betalain-rich microparticles from Opuntia ficus-indica, compared to conventional encapsulants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180323 |
|
| RJ01 | Rejection of invention patent application after publication |